Address
Email address
Phone number
https://chemi-pharm.comChemi-Pharm | Allergen-Free Disinfection ProductsChemi-Pharm AS develops, produces and sells allergen-free disinfection agents, cleansing and skincare products and detergents. Learn more!
Name
Ennevar OÜ
Registry code
10940744
VAT number
EE100826524
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.04.2003 (21)
Financial year
01.01-31.12
Capital
2 684.00 €
Activity
41201 - Construction of residential and non-residential buildings
8 160 €
7 405 €
91%
-
105 478 €
0
Submitted
No tax arrears
7%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Meelis Liigsoo 30.10.1967 (56) | 100% - 2 684.00 EUR | Board member | Direct ownership | |
| Projektijuht Aare OÜ 10613420 | - | - | - | Founder |
| 2019 06.07.2020 | 2020 09.06.2021 | 2021 26.05.2022 | 2022 31.05.2023 | 2023 21.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 33 875 € | 16 682 € | 15 100 € | 32 394 € | 8 160 € |
| Net profit (loss) for the period | 189 € | -762 € | 8 714 € | 4 533 € | 7 405 € |
| Profit Margin | 1% | -5% | 58% | 14% | 91% |
| Current Assets | 92 254 € | 84 826 € | 93 740 € | 98 671 € | 391 486 € |
| Fixed Assets | 4 381 € | 0 € | 0 € | 0 € | - |
| Total Assets | 96 635 € | 84 826 € | 93 740 € | 98 671 € | 391 486 € |
| Current Liabilities | 11 539 € | 0 € | 200 € | 598 € | 0 € |
| Non Current Liabilities | - | - | - | - | 286 008 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 85 096 € | 84 826 € | 93 540 € | 98 073 € | 105 478 € |
| Employees | 1 | 1 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | - | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | 8 160 € | 1 032 € | - | - |
| 2023 Q1 | 2 170 € | - | - | - |
| 2022 Q4 | 11 987 € | 110.84 € | - | - |
| 2022 Q3 | 9 252.14 € | 251.5 € | - | - |
| 2022 Q2 | 7 585 € | 632.24 € | - | - |
| 2022 Q1 | 2 500 € | 205.96 € | - | - |
| 2021 Q4 | 10 000 € | 1 176.15 € | - | - |
| 2021 Q3 | 4 000 € | 631.89 € | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | - |
| 2020 Q4 | - | - | - | - |
| 2020 Q3 | 2 261.38 € | 671.08 € | 437.1 € | 1 |
| 2020 Q2 | 10 174.45 € | 2 008.96 € | 558.99 € | 2 |
| 2020 Q1 | 6 544.09 € | 1 101.96 € | 375.22 € | 2 |
